Endpoints AI Day highlights agents, AI slop and biosecurity gaps in pharma

Endpoints News held its third AI Day, an event dedicated to exploring how artificial intelligence can be applied across drug discovery and development.

Speakers, including Nathan Frey of Anthropic, discussed the emergence of AI agents that can autonomously design experiments and the challenges of “AI slop,” the variability and noise that can arise when models are applied to real‑world data.

The conference also addressed the growing biosecurity gap, warning that advances in AI could be misused and calling for stronger safeguards within the biopharma community.

Organizers said the event fills a niche not covered by traditional pharma meetings or pure machine‑learning conferences, aiming to bring together scientists, engineers and regulators to shape the future of AI‑driven therapeutics.